You have 9 free searches left this month | for more free features.

Parainfluenza

Showing 1 - 25 of 147

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Human Metapneumovirus and Human Parainfluenza Infection Trial in United States (mRNA-1653, Placebo)

Completed
  • Human Metapneumovirus and Human Parainfluenza Infection
  • mRNA-1653
  • Placebo
  • Birmingham, Alabama
  • +18 more
Feb 2, 2023

SARS-CoV-2 Infection Trial in Baltimore (B/HPIV3/S-6P)

Recruiting
  • SARS-CoV-2 Infection
  • B/HPIV3/S-6P
  • Baltimore, Maryland
    Johns Hopkins Bloomberg School of Public Health
Aug 30, 2023

Ebola Virus Disease Trial in Baltimore (HPIV3/?HNF/EbovZ GP vaccine, Placebo)

Suspended
  • Ebola Virus Disease
  • HPIV3/ΔHNF/EbovZ GP vaccine
  • Placebo
  • Baltimore, Maryland
  • +1 more
Mar 2, 2022

Covid19 Trial in United States (CVXGA1 low dose, CVXGA1 high dose)

Recruiting
  • Covid19
  • CVXGA1 low dose
  • CVXGA1 high dose
  • Bardstown, Kentucky
  • +3 more
Aug 16, 2022

Lower Respiratory Tract Infection, Parainfluenza, Immunocompromised Trial in Worldwide (DAS181, Placebo, DAS181 COVID-19)

Recruiting
  • Lower Respiratory Tract Infection
  • +3 more
  • Duarte, California
  • +59 more
Jun 3, 2022

Respiratory Tract Viral Infections, Human Metapneumovirus (hMPV) Infection, Parainfluenza (PIV) Infection Trial in United States

Recruiting
  • Respiratory Tract Viral Infections
  • +4 more
  • ALVR106
  • Placebo
  • Scottsdale, Arizona
  • +19 more
Apr 13, 2022

Parainfluenza Infection Trial (DAS181, Placebo)

Withdrawn
  • Parainfluenza Infection
  • (no location specified)
Dec 14, 2019

Human Metapneumovirus and Human Parainfluenza Infection Trial in Omaha, Austin, Fort Worth (mRNA-1653, Placebo)

Completed
  • Human Metapneumovirus and Human Parainfluenza Infection
  • mRNA-1653
  • Placebo
  • Omaha, Nebraska
  • +2 more
Feb 5, 2020

Respiratory Viral Infection, in Prediction of Bronchiolitis

Unknown status
  • Allogeneic Hematopoietic Stem Cell Recipients
  • +2 more
  • samples
  • Paris, Ile De France, France
    Saint Louis
Feb 7, 2020

Respiratory Viral Infection, Common Cold, Severe Acute Respiratory Syndrome (SARS) Pneumonia Trial in Vienna (nasal spray)

Completed
  • Respiratory Viral Infection
  • +4 more
  • nasal spray
  • Vienna, Austria
  • +1 more
Aug 24, 2022

Respiratory Tract Infections Trial (Respiratory pathogen panel PCR test, COVID-19 antibody test)

Not yet recruiting
  • Respiratory Tract Infections
  • Respiratory pathogen panel PCR test
  • COVID-19 antibody test
  • (no location specified)
May 8, 2023

COVID-19 Trial (CVXGA1)

Not yet recruiting
  • COVID-19
  • CVXGA1
  • (no location specified)
Feb 17, 2023

White Blood Cells Engulfing Red Blood Cells Trial in Brussel (No intervention, observational study)

Recruiting
  • White Blood Cells Engulfing Red Blood Cells
  • No intervention, observational study
  • Brussel, Belgium
    UZ Brussel
Jan 30, 2023

QuidelOrtho Savanna RVP4 Analyzer

Not yet recruiting
  • Respiratory Viral Infection
    • (no location specified)
    Apr 26, 2023

    Viral Infections, Bone Marrow Transplant Infection Trial in Washington (Virus Specific T cells (VSTs))

    Recruiting
    • Viral Infections
    • Bone Marrow Transplant Infection
    • Virus Specific T cells (VSTs)
    • Washington, District of Columbia
      Childrens National Medical Center
    Oct 12, 2021

    Hematological Disorders Associated With COVID-19 Infection

    Completed
    • Hematological Condition With COVID19
      • Assiut, Egypt
        Facility of medicine
      Jan 6, 2023

      Non-Genital Warts Trial (garlic extract (15%) solution, topical chlorhexidine (2%) solution, Saline)

      Not yet recruiting
      • Non-Genital Warts
      • garlic extract (15%) solution
      • +2 more
      • (no location specified)
      Oct 13, 2023

      Unit Healthy Volunteer Protocols

      Recruiting
      • Zika
      • Influenza
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        Aug 24, 2022

        COVID-19 Trial in Lahore (standard of care for COVID-19 as per the hospital guidelines, Quercetin Phytosome (QP))

        Completed
        • COVID-19
        • standard of care for COVID-19 as per the hospital guidelines
        • Quercetin Phytosome (QP)
        • Lahore, Punjab, Pakistan
          King Edward Medical University Teaching Hospital
        Jan 23, 2022

        Covid19 Trial in Vienna (Carragelose, NaCl)

        Recruiting
        • Covid19
        • Carragelose
        • NaCl
        • Vienna, Austria
          Gesundheitsverbund, Klinik Floridsdorf
        Mar 10, 2021

        Burden of Respiratory Syncytial Virus in Sweden: A Retrospective

        Active, not recruiting
        • Respiratory Syncytial Virus (RSV)
          • (no location specified)
          Nov 10, 2022

          Bronchiolitis Trial in Sohag (Vitamin D3)

          Recruiting
          • Bronchiolitis
          • Vitamin D3
          • Sohag, Egypt
            Sohag University Hospital
          Apr 1, 2023

          Respiratory Syncytial Virus Infections Trial in Cincinnati, North Charleston (CPI-RSV-F Vaccine (BLB-201))

          Completed
          • Respiratory Syncytial Virus Infections
          • CPI-RSV-F Vaccine (BLB-201)
          • Cincinnati, Ohio
          • +1 more
          Dec 5, 2022

          Wheezing, Recurrent Respiratory Tract Infections Trial in Naples (Resveratrol + CMG, Isotonic solution)

          Recruiting
          • Wheezing
          • Recurrent Respiratory Tract Infections
          • Resveratrol + CMG
          • Isotonic solution
          • Naples, Italy
            University of Campania Luigi Vanvitelli
          Jan 13, 2023

          Respiratory Syncytial Virus Infections Trial in Cincinnati (PIV5-vectored RSV Vaccine (BLB-201) Low Dose, PIV5-vectored RSV

          Not yet recruiting
          • Respiratory Syncytial Virus Infections
          • PIV5-vectored RSV Vaccine (BLB-201) Low Dose
          • +2 more
          • Cincinnati, Ohio
            Cincinnati Children's Hospital Medical Center
          Dec 20, 2022